Thyrocare Technologies Limited — Important, 03-02-2025: Updates

Thyrocare Technologies Limited submitted an updated limited review report on consolidated financial results for the nine months ended December 31, 2024. A clerical error during the scanning process led to the omission of specific points in the earlier submission; however, this has been corrected without affecting the financial results. The company reported revenue from operations at ₹156.06 Cr for the quarter, reflecting a significant increase from ₹124.98 Cr year-on-year. For the nine-month period, revenue was ₹468.03 Cr, up from ₹387.16 Cr in the previous year. Profit after tax for the quarter stood at ₹19.10 Cr, compared to ₹14.89 Cr last year. The strong performance signals ongoing operational efficiency and growth potential, indicating a positive outlook for investors. Additionally, the company successfully completed acquisitions of diagnostic businesses and is actively reassessing operational efficiencies for its testing machines. Investors may want to monitor developments closely for further growth opportunities.